Page last updated: 2024-12-06

hs 310

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chandonium iodide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71537
CHEMBL ID2106112
SCHEMBL ID12506217
MeSH IDM0049817

Synonyms (15)

Synonym
chandonium iodide
hs-310
candocuronium iodide
CHEMBL2106112
17a,17a-dimethyl-3beta-(1-methylpyrrolidinio)-17a-azonia-d-homoandrost-5-ene diiodide
17a-methyl-3-beta-pyrrolidino-17a-aza-dihomoandrost-5-ene dimethiodide
17a-azonia-d-homoandrost-5-ene, 17alpha,17alpha-dimethyl-3-(1-methylpyrrolidinio)-, diiodide, (3beta)-
unii-sc80gnp08c
candocuronium iodide [inn]
hs 310
sc80gnp08c ,
17a,17a-dimethyl-3.beta.-(1-methylpyrrolidinio)-17a-azonia-d-homoandrost-5-ene diiodide
SCHEMBL12506217
Q5032016
DTXSID60969306
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (80.00)18.7374
1990's2 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.83 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index99.56 (26.88)
Search Engine Supply Index3.97 (0.95)

This Compound (37.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (18.18%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]